The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

London pre-open: Small rise expected in early trading

Thu, 26th Apr 2012 07:39

City sources predict the FTSE 100 will open up 13 points from yesterday's close of 5,719, following comments from Federal Reserve Chairman Ben Bernanke on Wednesday that US monetary policy was 'more or less in the right place', indicating further quantitative easing in the near-term is unlikely. AstraZeneca said profits fell by more than a third in the first quarter after a number of patents ran and it was hit by tough market conditions. Revenues came in well below market expectations, falling 11% to $7.349bn, short of consensus forecasts for revenue of $7,874m. Loss of exclusivity on several key brands accounted for eight percentage points of the revenue decline, the firm said.Integrated oil and gas titan Royal Dutch Shell's upstream activities drove a bigger than expected increase in the Anglo-Dutch group's first quarter earnings. Underlying earnings on a current cost of supplies (CCS) basis rose to $7,279m from $6,288m in the corresponding quarter of 2011. Charles Stanley analyst Tony Shepard had pencilled in a figure for earnings after tax of $6.5bn.Adjusted profits at UK lender Barclays surged by over a fifth in the first quarter of 2012, well above expectations. Adjusted pre-tax jumped 22% from £2,004m registered in the first quarter of 2011 to £2,445m this year. Consensus estimates were for a reading of £2,006m. Adjusted results exclude the impact of £2,620m own credit reversal (2011: £351m), £300m in provisions for PPI redress (2011: nil) and any gains on acquisitions and disposals (2012: nil, 2011: £2m).

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.